GM-CSF Induces Inflammatory Macrophages by Regulating Glycolysis and Lipid Metabolism

Yi Rang Na1, Gyo Jeong Gu1, Daun Jung1

  • 1Macrophage Laboratory, Department of Microbiology and Immunology, Institute of Endemic Disease, Seoul National University College of Medicine, Seoul 110-799, South Korea.

Insights

Granulocyte-macrophage colony-stimulating factor (GM-CSF) drives inflammatory macrophages by boosting glycolysis and the mevalonate pathway. Inhibiting these metabolic processes reduces inflammation, offering potential therapeutic targets.

Area of Science:

  • Immunology
  • Metabolic pathways
  • Cellular biology

Background:

  • Granulocyte-macrophage colony-stimulating factor (GM-CSF) is known to induce proinflammatory macrophages.
  • The precise molecular mechanisms underlying GM-CSF-induced macrophage inflammation remain largely unelucidated.
  • Understanding these mechanisms is crucial for developing targeted immunotherapies.

Purpose of the Study:

  • To investigate the metabolic mechanisms by which GM-CSF induces inflammatory macrophages.
  • To determine the role of glycolysis and the mevalonate pathway in GM-CSF-driven macrophage activation.
  • To explore the therapeutic potential of targeting these metabolic pathways in inflammatory conditions.

Main Methods:

  • Murine bone marrow-derived macrophages were stimulated with GM-CSF and lipopolysaccharide (LPS).
  • Glycolysis was inhibited using 2-deoxyglucose; the mevalonate pathway was inhibited using specific inhibitors.
  • Glucose transporter (GLUT) and c-myc expression were assessed.
  • Dextran sodium sulfate (DSS)-induced colitis mouse models were used, with analysis of GLUT-1 expression and positron emission tomography (PET) imaging.

Main Results:

  • GM-CSF significantly increased LPS-induced glycolysis and the expression of GLUT-1, -3, -4, and c-myc.
  • Inhibition of glycolysis or the mevalonate pathway abrogated GM-CSF-mediated pro-inflammatory cytokine production (TNF-α, IL-1β, IL-6, IL-12p70).
  • In vivo studies showed increased [18F]-fluorodeoxyglucose uptake in GLUT-1high macrophages in inflamed colons, which was reduced by GM-CSF neutralization.

Conclusions:

  • GM-CSF primes macrophages for inflammation by enhancing glycolysis and the mevalonate pathway.
  • Targeting glycolysis and lipid metabolism represents a novel strategy for controlling GM-CSF-induced inflammatory macrophage functions.
  • These metabolic pathways are critical determinants of inflammatory macrophage phenotype and function.